Strem and Codexis Sign Enzyme Distribution Agreement

  Strem and Codexis Sign Enzyme Distribution Agreement

Business Wire

NEWBURYPORT, Mass. & REDWOOD CITY, Calif. -- February 19, 2013

Strem Chemicals, Inc., a manufacturer of specialty chemicals for research and
development and Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading
enzymes and processes for the production of pharmaceuticals, biofuels and
bio-based chemicals, today announced the signing of an enzyme distribution
agreement.

The agreement grants Strem exclusive distribution rights for the new 100mg
CODEX^® Screening Kits for Codexis’ popular Transaminase and Ketoreductase
enzyme platforms. These enzymes enable efficient conversion of ketones to
chiral alcohols or amines.

The screening kits contain enzymes evolved with proprietary CodeEvolver^®
directed evolution technology. The resulting enzymes are designed to work at
industrial process conditions while reducing cost and waste. They will be
available through Strem’s overnight delivery service so that researchers are
able to quickly screen a small number of diverse biocatalysts to pick the best
solution.

“We are pleased to announce this partnership with Strem, a company very well
established in the distribution of catalysts to a wide customer base,” said
Dr. Peter Seufer-Wasserthal, Senior Vice President, Pharmaceuticals at
Codexis. “Based on Strem’s proven network, we are looking forward to giving
more customers the opportunity to use industrial enzymes at R&D scale.”

“Strem is pleased to be working with a proven market leader in the field of
Biocatalysis,” said Ephraim Honig, Chief Operating Officer at Strem. “The
addition of these screening kits broadens the range of synthesis tools we
offer our customers and acknowledges the increasingly important role this
technology plays in drug discovery and development.”

About Strem Chemicals

Strem Chemicals, Inc., established in 1964, is a privately held manufacturer
and marketer of specialty chemicals of high purity. Strem’s key products
include catalysts, ligands, organometallics, metal carbonyls and
nanomaterials. Its products are used for research and development and
commercial scale applications, especially in the pharmaceutical,
microelectronics, chemicals and petrochemicals industries. Strem Chemicals
also provides custom synthesis, process development and cGMP manufacturing
services. For more information visit www.strem.com.

About Codexis, Inc.

Codexis, Inc. is a developer of world-leading enzymes and processes for the
production of pharmaceuticals, biofuels and bio-based chemicals. Codexis'
product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent
alcohol. Partners and customers include global leaders such as Merck, Pfizer
and Arch Pharmalabs. For more information, see www.codexis.com.

Contact:

Strem Chemicals, Inc.
Media: press@strem.com
or
Codexis, Inc.
Investors:
Paul Cox, 212-362-1200
ir@codexis.com
Media:
media@codexis.com
 
Press spacebar to pause and continue. Press esc to stop.